| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.24 | 2e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |